Clinical trial
A Phase II Study of Imatinib and Valproic Acid in Patients With CML
NCT01011998 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Imatinib and Valproic Acid in Patients With CML
- Lead sponsor
- New Mexico Cancer Research Alliance
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- September 30, 2009
- Completion date
- July 31, 2010
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic myelogenous leukemia